• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约旦的视网膜母细胞瘤:一项流行病学研究(2006 - 2010年)

Retinoblastoma in Jordan: an epidemiological study (2006-2010).

作者信息

Jaradat Imad, Yousef Yacoub A, Mehyar Mustafa, Sultan Iyad, Khurma Samer, Al-Rawashded Khalil, Wilson Matt, Qaddoumi Ibrahim, Salem Ahmed, Alnawaiseh Ibrahim

机构信息

King Hussein Cancer Center, Amman, Jordan.

出版信息

Hematol Oncol Stem Cell Ther. 2011;4(3):126-31. doi: 10.5144/1658-3876.2011.126.

DOI:10.5144/1658-3876.2011.126
PMID:21982886
Abstract

BACKGROUND AND OBJECTIVE

The epidemiological characteristics of retinoblastoma have been extensively studied in developed countries, however epidemiological data is scarce in the Middle East. We present a de- tailed epidemiological analysis of retinoblastoma in Jordan in an attempt to aid national and regional strategies for improved cancer surveillance and control.

DESIGN AND SETTING

Retrospective review of retinoblastoma cases presenting to the sole and exclusive ocular oncology referral center in Jordan.

PATIENTS AND METHODS

Forty children (59 eyes) presenting with clinically and/or histologically confirmed retinoblastomas were treated at King Hussein Cancer Center (Amman, Jordan) between January 2006 and December 2010. This case series included 28 boys and 12 girls. Data relating to age at diagnosis, laterality, gender, treatment modality and survival were recorded.

RESULTS

The mean age-adjusted incidence of retinoblastoma in Jordan was 9.32 cases per million children per year for children aged 0-5 years. The male: female ratio was 2.3:1. Bilateral cases were encountered in 19 pa- tients (47.5%) while 21 patients (52.5%) harbored unilateral retinoblastoma. At the time of follow-up, 38 patients (95%) were alive. Overall, 40 eyes (67.8%) were successfully preserved without the need for enucleation.

CONCLUSIONS

The national epidemiological data gathered in this study indicates that the incidence of retinoblastoma in Jordan is similar to that reported in various countries of the world. Jordanian boys, however, are at significantly higher risk for developing retinoblastoma than age-matched girls. Furthermore, Jordanian patients are more likely to harbor bilateral retinoblastoma.

摘要

背景与目的

视网膜母细胞瘤的流行病学特征在发达国家已得到广泛研究,然而中东地区的流行病学数据却很匮乏。我们对约旦的视网膜母细胞瘤进行了详细的流行病学分析,以期为国家和地区改善癌症监测与控制的策略提供帮助。

设计与背景

对约旦唯一的眼科肿瘤转诊中心接收的视网膜母细胞瘤病例进行回顾性研究。

患者与方法

2006年1月至2010年12月期间,40名临床和/或组织学确诊为视网膜母细胞瘤的儿童(共59只眼)在侯赛因国王癌症中心(约旦安曼)接受治疗。该病例系列包括28名男孩和12名女孩。记录了诊断时的年龄、患侧、性别、治疗方式和生存情况等数据。

结果

约旦0至5岁儿童中,视网膜母细胞瘤的年龄调整后平均发病率为每年每百万儿童9.32例。男女比例为2.3:1。19名患者(47.5%)为双侧病例,21名患者(52.5%)为单侧视网膜母细胞瘤。随访时,38名患者(95%)存活。总体而言,40只眼(67.8%)成功保留,无需眼球摘除。

结论

本研究收集的国家流行病学数据表明,约旦视网膜母细胞瘤的发病率与世界各国报道的相似。然而,约旦男孩患视网膜母细胞瘤的风险明显高于同龄女孩。此外,约旦患者更易患双侧视网膜母细胞瘤。

相似文献

1
Retinoblastoma in Jordan: an epidemiological study (2006-2010).约旦的视网膜母细胞瘤:一项流行病学研究(2006 - 2010年)
Hematol Oncol Stem Cell Ther. 2011;4(3):126-31. doi: 10.5144/1658-3876.2011.126.
2
Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.2003 - 2013年约旦的视网膜母细胞瘤:眼部生存率及相关因素
Ophthalmic Epidemiol. 2014 Dec;21(6):406-11. doi: 10.3109/09286586.2014.967781. Epub 2014 Oct 15.
3
Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020).约旦的视网膜母细胞瘤和葡萄膜黑色素瘤:发病率、人口统计学和生存情况(2011-2020 年)。
Ophthalmic Genet. 2023 Apr;44(2):119-126. doi: 10.1080/13816810.2022.2090008. Epub 2022 Jul 17.
4
Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan.视网膜母细胞瘤的团队管理、结对帮扶及远程医疗:约旦首个眼部挽救计划中实施的三级方法
Pediatr Blood Cancer. 2008 Aug;51(2):241-4. doi: 10.1002/pbc.21489.
5
Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome.建立一个正式的视网膜母细胞瘤项目:跨境临床协调的可行性及其对结果的影响。
Pediatr Blood Cancer. 2019 Nov;66(11):e27959. doi: 10.1002/pbc.27959. Epub 2019 Aug 18.
6
[Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center].[视网膜母细胞瘤:卡萨布兰卡大学医学中心国家治疗方案的初步结果]
J Fr Ophtalmol. 2014 Feb;37(2):115-24. doi: 10.1016/j.jfo.2013.05.027. Epub 2014 Feb 5.
7
A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.在约旦一家三级癌症中心对50只因视网膜母细胞瘤而主要被摘除的眼睛进行的组织病理学分析。
Turk Patoloji Derg. 2014;30(3):171-7. doi: 10.5146/tjpath.2014.01260.
8
Retinoblastoma in Karachi, Pakistan.巴基斯坦卡拉奇的视网膜母细胞瘤。
Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):159-63.
9
Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.来自监测、流行病学和最终结果(SEER)登记处的1452例视网膜母细胞瘤的流行病学趋势。
Can J Ophthalmol. 2017 Dec;52(6):592-598. doi: 10.1016/j.jcjo.2017.05.012. Epub 2017 Jul 22.
10
Updated retinoblastoma incidence and outcome in children in Taiwan from 1980 to 2019: a 40-year nationwide study.更新 1980 年至 2019 年台湾地区儿童视网膜母细胞瘤发病和结局:一项 40 年全国性研究。
Eye (Lond). 2024 Jun;38(8):1535-1541. doi: 10.1038/s41433-024-02946-0. Epub 2024 Feb 2.

引用本文的文献

1
Molecular heterogeneity and MYC dysregulation in triple-negative breast cancer: genomic advances and therapeutic implications.三阴性乳腺癌中的分子异质性与MYC失调:基因组学进展及治疗意义
3 Biotech. 2025 Jan;15(1):33. doi: 10.1007/s13205-024-04195-0. Epub 2025 Jan 5.
2
Incidence of retinoblastoma in children and adolescents in Brazil: A population-based study.巴西儿童和青少年视网膜母细胞瘤的发病率:一项基于人群的研究。
Front Pediatr. 2022 Nov 23;10:1048792. doi: 10.3389/fped.2022.1048792. eCollection 2022.
3
Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy.
提高医学生对视网膜母细胞瘤的认识:一项实用策略。
Clin Ophthalmol. 2022 Jun 7;16:1807-1814. doi: 10.2147/OPTH.S355876. eCollection 2022.
4
The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.第八版临床 TNM 分期系统对眼内视网膜母细胞瘤全身化疗和局部治疗后保眼可能性的预测价值。
J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e841-e847. doi: 10.1097/MPH.0000000000002144.
5
[Epidemio-clinical features of retinoblastoma at the Yalgado Ouedraogo University Hospital Center in Burkina Faso: about 32 cases].布基纳法索亚尔加杜·韦德拉奥果大学医院中心视网膜母细胞瘤的流行病学临床特征:约32例病例
Pan Afr Med J. 2020 Nov 25;37:269. doi: 10.11604/pamj.2020.37.269.20556. eCollection 2020.
6
Prognostic Factors for Eye Globe Salvage by External Beam Radiation Therapy for Resistant Intraocular Retinoblastoma.外照射放疗挽救耐药性眼内视网膜母细胞瘤眼球的预后因素
Oman J Ophthalmol. 2020 Nov 2;13(3):123-128. doi: 10.4103/ojo.OJO_250_2019. eCollection 2020 Sep-Dec.
7
Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.视网膜母细胞瘤:来自印度北部一家三级护理机构的16年临床表现、治疗及结果回顾。
Ocul Oncol Pathol. 2017 Dec;4(1):23-32. doi: 10.1159/000477408. Epub 2017 Jul 5.
8
Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.约旦RB1基因的突变分析及视网膜母细胞瘤的遗传模式
Fam Cancer. 2018 Apr;17(2):261-268. doi: 10.1007/s10689-017-0027-5.
9
Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy.既往仅接受全身化疗而未接受局部治疗的视网膜母细胞瘤患者的治疗结局。
Oman J Ophthalmol. 2017 May-Aug;10(2):70-75. doi: 10.4103/ojo.OJO_225_2015.
10
Familial Retinoblastoma: Raised Awareness Improves Early Diagnosis and Outcome.家族性视网膜母细胞瘤:提高认识可改善早期诊断及预后。
J Ophthalmol. 2017;2017:5053961. doi: 10.1155/2017/5053961. Epub 2017 Mar 2.